Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Corneal Neovascularization D016510 8 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Venous Thrombosis D020246 11 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Chand N et al. Effect of PAF-antagonists on aeroallergen-induced bronchial eosinophilia in guinea pigs: a therapeutic approach. 1994 Res. Commun. Mol. Pathol. Pharmacol. pmid:7850258
Dupuis F et al. Production and metabolism of platelet-activating factor by human bone marrow cells. 1997 Res. Immunol. pmid:9226766
Denizot Y et al. Modulation of gut wall paf-acether and precursors by intestinal microflora. 1990 Mar-Apr Res. Immunol. pmid:2218055
Denizot Y et al. Effects of platelet-activating factor on human T and B cells--an overview. 1994 Res. Immunol. pmid:8079043
Alviano DS et al. Differentiation of Fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by platelet-activating factor. 2003 Res. Microbiol. pmid:14643407
Muehlmann LA et al. PAF increases phagocytic capacity and superoxide anion production in equine alveolar macrophages and blood neutrophils. 2012 Res. Vet. Sci. pmid:21820686
Conejeros I et al. 2-Aminoethoxydiphenyl borate (2-APB) reduces respiratory burst, MMP-9 release and CD11b expression, and increases l-selectin shedding in bovine neutrophils. 2012 Res. Vet. Sci. pmid:21071047
Fairbairn SM et al. Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary disease. 1996 Res. Vet. Sci. pmid:8880978
Foster AP et al. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro. 1992 Res. Vet. Sci. pmid:1332153
Bailey SR et al. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. 2000 Res. Vet. Sci. pmid:10756136
Hammond A et al. Platelets in equine recurrent airway obstruction. 2007 Res. Vet. Sci. pmid:17107696
Jarvis GE and Evans RJ Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro. 1994 Res. Vet. Sci. pmid:7871251
Marr KA et al. Effect of antigen challenge on the activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease. 1997 May-Jun Res. Vet. Sci. pmid:9300544
Akbarshahi H et al. Acute lung injury in acute pancreatitis--awaiting the big leap. 2012 Respir Med pmid:22749752
Echazarreta AL et al. Lack of systemic oxidative stress during PAF challenge in mild asthma. 2005 Respir Med pmid:15823446
Kroegel C et al. Cytokines, platelet activating factor and eosinophils in asthma. 1992 Respir Med pmid:1462017
Barnes NC New developments in the treatment of asthma and chronic obstructive pulmonary disease. 1993 Respir Med pmid:7901879
Inoue T and Kannan MS Platelet-activating factor-induced functional changes in the guinea pig trachea in vitro. 1989 Respir Physiol pmid:2781159
Marcano H et al. Effect of dopamine on platelet activating factor induced-pulmonary edema in isolated and perfused rabbit lungs. 2001 Respir Physiol pmid:11348642
Pesce L et al. Effect of Fenoterol on PAF-induced lung edema in isolated and perfused rabbit lungs. 1998 Respir Physiol pmid:9865589
Friedman E et al. Effect of hydrocortisone on platelet activating factor induced lung edema in isolated rabbit lungs. 2000 Respir Physiol pmid:10786645
Steer ML Relationship between pancreatitis and lung diseases. 2001 Respir Physiol pmid:11535257
Raj JU et al. Effects of endothelin, platelet activating factor and thromboxane A2 in ferret lungs. 1992 Apr-May Respir Physiol pmid:1626132
Rastogi P and McHowat J Inhibition of calcium-independent phospholipase A2 prevents inflammatory mediator production in pulmonary microvascular endothelium. 2009 Respir Physiol Neurobiol pmid:19059366
Machado GB et al. Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. 2011 Respir. Res. pmid:21819560
Jiang Z et al. The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice. 2012 Respir. Res. pmid:23140447
Gebremichael I and Leuenberger P Platelet-activating factor does not induce bronchial hyperreactivity in nonasthmatic subjects. 1992 Respiration pmid:1485002
Block LH et al. PAF-dependent phosphatidylinositol turnover in platelets: differences between asthmatics and normal individuals. 1990 Respiration pmid:2099571
Tohda Y et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. 2001 Respiration pmid:11223734
Matheson MJ et al. Role of platelet activating factor, leukotrienes and polymorphs in the FMLP induced increase in microvascular leakage in rabbit trachea. 1997 Respirology pmid:9424405
Li HP et al. Effect of chinonin on acute hypoxic pulmonary vasoconstriction in Sprague-Dawley rats. 1998 Respirology pmid:9692515
Ruchaud-Sparagano MH et al. Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis. 2013 Respirology pmid:23730995
Hosford D et al. Platelet-activating factor and cytokine interactions in shock. 1989 Resuscitation pmid:2555874
Gedeborg R and Wiklund L Experimental model of cardiovascular post-resuscitation syndrome--no effect of platelet activating factor antagonism. 1998 Oct-Nov Resuscitation pmid:9918458
Egido J et al. [The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage]. 1990 Jul-Aug Rev Clin Esp pmid:2284487
Fité-Mora R Torsade de pointes associated with rupatadine. 2009 Rev Esp Cardiol pmid:19268083
Ais JG et al. [The physiopathology of acute pancreatitis: the role of platelet-activating factor (PAF)]. 1992 Rev Esp Enferm Dig pmid:1547030
Martin JG [Animal models of bronchial hyperreactivity]. 1994 Rev Mal Respir pmid:7515508
Nechifor M [Agonists and antagonists of the platelet activating factor (PAF)]. 1989 Oct-Dec Rev Med Chir Soc Med Nat Iasi pmid:2636782
Cijevschi I and Cijevschi D [Ocular immunopathological characteristics and the involvement of the platelet-aggregation factor and the anti-PAF at the level of the eye]. 1999 Jan-Jun Rev Med Chir Soc Med Nat Iasi pmid:10756889
Nechifor M [Agonists and antagonists of the platelet activating factor (PAF). II]. 1990 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:2100870
Leclercq M et al. [Effects of Hymenoptera stings: physiopathology and immunology according to recent literature findings]. 1985 Rev Med Liege pmid:2418479
Santos OF et al. [Platelet activating factor in nephrology: physiopathologic and therapeutic perspectives]. 1988 Jul-Aug Rev Paul Med pmid:3076976
Massion PB and Frans A [Role of platelet activating factor and its antagonists in bronchial asthma]. 1992 Rev Pneumol Clin pmid:1384101
Charbonneau P and Suisse A [Syndrome of multiple organ failure]. 1990 Rev Prat pmid:2263856
Romero A et al. [Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)]. 1988 Rev. Esp. Fisiol. pmid:3072620
Santos JC et al. Effect of intrarenal infusion of synthetic PAF-acether in dogs. 1988 Rev. Esp. Fisiol. pmid:3231880
Brochet B et al. [Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis]. 1992 Rev. Neurol. (Paris) pmid:1439458
Simmet T and Peskar BA Eicosanoids and the coronary circulation. 1986 Rev. Physiol. Biochem. Pharmacol. pmid:3520775
Sperling RI Dietary omega-3 fatty acids: effects on lipid mediators of inflammation and rheumatoid arthritis. 1991 Rheum. Dis. Clin. North Am. pmid:1862246